Red Light Holland Successfully Imports 200 Psilocybin iMicro
Red Light Holland Successfully Imports 200 Psilocybin iMicrodose Packs, Sold in The Netherlands, Into Canada Under a Third Health Canada Approved Psilocybin Import Permit To cGMP Laboratory
2022-05-16 08:15 ET - News Release
-
Red Light Holland proudly exports a commercial sale of 3000 Grams (200 x 15g packs) of Psilocybin Truffles (Psilocybe Tampanensis) grown in the Company's Farm in Horst, The Netherlands to its laboratory partner, CCrest Laboratories Inc., a cGMP pharmaceutical laboratory in Montreal, Canada
-
Red Light Holland has an established alliance with CCrest Laboratories Inc. in partnership with Shaman Pharma Corp., who have been listed by Health Canada as a Psilocybin supplier to the Special Access Program.
-
CCrest Laboratories will continue to perform stability tests and R&D towards creating a standardized consistent dose from naturally occurring psilocybin truffles.
Toronto, Ontario--(Newsfile Corp. - May 16, 2022) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of it's Psilocybin magic truffles, is pleased to announce that it has completed the third export of the company's freshly harvested high-grade psilocybe truffles, from the Netherlands to Canada, under a Health Canada psilocybin import permit awarded to CCrest Laboratories Inc. in partnership with Shaman Pharma Corp. CCrest Laboratories received 200 of Red Light Holland's psilocybe truffles kits, a total of 3 kg (200 x 15g packs) of Psilocybin Truffles (Psilocybe Tampanensis) grown in the Company's Farm in Horst, The Netherlands.
"I'm absolutely thrilled to have completed our third import and sale of our Psilocybin Truffles from the Netherlands to Canada to our partners CCrest Labs, who have been listed as a provider of Psilocybin for the Special Access Program by Health Canada," said Todd Shapiro, CEO and Director of Red Light Holland. "We thought it was important to ship a large number of our actual iMicrodose packs to CCrest Labs this time, in case they could ever be used by patients through the Special Access Program. This is just another milestone for Red Light Holland and our loyal shareholders."
"Our previous testing has shown that our truffles are suitable as a source of active pharmaceutical ingredients ("API") for scientific and potentially medical and therapeutic purposes and we are excited to continue the testing and R&D with our partners at CCrest Labs," said Sarah Haskes, CTIO of Red Light Holland. "We continue to move towards our goal of creating a standardized consistent dose from naturally occurring psilocybin truffles, which our market research shows people are interested in. This can potentially benefit both the recreational and medicinal markets and we continue our path to work within the careful means of the regulatory process with reliable partners in hopes of pushing for safe, responsible access to the company's naturally occurring psilocybin by testing, learning and educating the public and hopefully Governments right here in Canada and across the world."
CCrest Laboratories, a cGMP pharmaceutical laboratory in Montreal specializing in highly regulated narcotics, including psychedelics, holds a Health Canada Controlled Drugs and Substances License, and received federally issued import permits for the restricted drug Psilocybin. CCrest has also been listed as a provider of Psilocybin for the Special Access Program in Canada.
Shaman Pharma, working in conjunction with CCrest Laboratories, is developing cGMP compliant scientific methods and protocols of Quality Control, Analysis and Extraction, aimed at industrial-scale commercialization of medical purpose psychedelic substances in this emerging pharmaceutical sector. Together with Red Light Holland, the companies are setting the pace at which regulatory requirements are exceeded, opening a new realm of possibilities for disruptive healthcare innovation.
"This third shipment marks the continuation of the previously announced progress achieved between Red Light Holland and CCrest Labs," commented Alex Grenier, CEO of Shaman Pharma and President of CCrest Laboratories. "Notable points are that we have a 100% success rate while increasing quantities, it looks promising for a certain maturity and scale in a supply chain that had not been achieved until now. We set out to demonstrate beyond any doubt that patients, and responsible adults in general, should be able to reliably and safely access psilocybin from natural sources. While much research remains, so far there doesn't seem to be any impurities or toxins present that would disqualify a natural source. Actually, to us it is rapidly becoming more interesting to study than pure (synthetic) psilocybin. Simply put, it's a richer platform for discovery, and we would hate to miss out on something that nature has potentially perfected."
Making larger quantities available to the scientists enables deepening the research into the composition of the raw materials - the scientific protocols are now expanded for the detection and quantification of other active ingredients known to exist alongside psilocybin and psilocin, mainly the compounds norpsilocin, baeocystin, norbaeocystin and aeruginascin. While expected to be present in very small quantities, they could prove to have large modulation effects. This could arguably establish a new realm of possibilities beyond simple dosage of psilocybin, where a near infinite number of combinations exist between the various compounds.
About Red Light Holland
Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles.